• extensively studied in Europe.

  • improves cerebral circulation (causes a mild dilation of blood vessels allowing for increased cerebral blood flow resulting in increased oxygenation and glucose utilization)

  • enhances memory

  • promotes higher mental acuity and awareness

  • enhances cognitive functions

  • increases brain-cell energy through its effect on the production of ATP

  • promotes alertness, awareness, and preparedness

  • enhances oxygen delivery to the brain, muscle, and liver

  • improves hearing function

  • improves visual function

  • improves cardiovascular function


For more information on each of the ingredients in the DRIVE™ formula, please click on the links below:

Taurine  |  Rhodiola Rosea  |  Caffeine  |
Vinpocetine  |  B-Vitamins

 Scientific Research Supporting Vinpocetine:
  1. Balestreri R, Fontana L, Astengo, F. (1987) A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc, 35(5): 425-430.

  2. Bhatti JZ, Hindmarch I. (1987) Vinpocetine Effects on Cognitive Impairments Produced by Flunitrazepam. Inter Clin Psychopharmacology, 2: 325-331.

  3. Bonoczk P, Gulyas B, Adam-Vizi V, et al. (2000) Role of sodium chanel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull, 53(3): 245-54.

  4. Burtsev EM, Savkov VS, Shprakh VV, Burtsev, ME. (1992) 10-years experience with using Cavinton in cerebrovascular disorders. Zh Nevropatol Psikhiatr Im S S Korsakova, 92(1): 56-60.

  5. Hindmarch I, Fuchs HH, Erzigkeit H. (1991) Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol, 6(1): 31-43.

  6. Kiss B, Karpati E. (1996) Mechanism of action of vinpocetine. Acta Pharm Hung, 66 (5): 213-24.

  7. Maslarova J, Nikolov R. (1999) Antihypoxic effect of vinpocetine. Works of the Chemical Pharmaceutical Research Institute, XIX, 175-182 (In Bulgarian).

  8. Orosz E, Deak Gy, Benoist,Gy. (1976) Effect of ethyl apovincaminate on the cerebral circulation. Arzneim-Forsch, 26(10a): 1951-56.

  9. Pálosi É, Szporny L. (1976) Effect of ethyl apovincaminate of the central nervous system. Arzneim-Forsch, 26(10a): 1926-29.

  10. Tamaki N, Kusunoki T, Matsumoto S. (1985) The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disordes. Therapia Hungarica, 33:13-21.